Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Beyond the Capsule: Unlocking the Full Potential of Lipid Excipients in Oral Solid Dosage Forms | Contract Pharma

What are you searching for?

Sign in
Sponsored Content

Beyond the Capsule: Unlocking the Full Potential of Lipid Excipients in Oral Solid Dosage Forms

This presentation highlights emerging research and formulation strategies that expand the use of lipid excipients in oral tablet development.

Released By Gattefossé USA

Lipid Excipients in Oral Solid Dosage Forms

Lipid excipients offer significant in vivo performance benefits for oral drug delivery by improving solubility/bioavailability, enhancing absorption, and mitigating food effect. While lipids have found commercial success in soft gel capsules and liquid-filled hard capsules, there is growing interest in incorporating the benefits of lipid excipients into oral solid dosage forms, such as tablets.

This presentation highlights emerging research and formulation strategies that expand the use of lipid excipients in oral tablet development. 

Key topics include:

  • In vivo benefits of lipid excipients for solubility and permeability.
  • Combining lipids with polymers to optimize oral tablet performance.
  • Incorporating lipids into tablets via common processing techniques.
  • Case studies showcasing lipid-enabled tablet formulations. 

Speaker:

Nick DiFranco – MEM Senior Marketing Manager – Pharmaceutical Division, Gattefossé USA

Request more information from Gattefossé USA

Request more information from Gattefossé USA

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics